Pre-treatment with the PTK inhibitor, genistein, significantly attenuated the inflammation-induced decrease in PWL in this arthritis model (88.47% of baseline, p < 0.01 compared to vehicle pretreated arthritic rats). Here, PTK2B is linked to arthritic joint disease.